Basic Information
NeuroTherapia is a Cleveland-based biotechnology company dedicated to developing the novel small molecule NTRX-07 for the treatment of neurodegenerative diseases. NTRX-07 is an orally available small molecule that targets receptors known to be upregulated in diseases including Alzheimer's disease (AD), ALS, MS, and chronic pain syndromes.
NeuroTherapia, Inc.
Cleveland,Ohio,United States of America
less than 15 people
January 01, 2015
info@neurotherapia.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios